347 718

Cited 25 times in

Decrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes

DC Field Value Language
dc.contributor.author안철우-
dc.contributor.author이현철-
dc.contributor.author임승길-
dc.contributor.author차봉수-
dc.contributor.author강은석-
dc.date.accessioned2015-06-10T12:07:03Z-
dc.date.available2015-06-10T12:07:03Z-
dc.date.issued2006-
dc.identifier.issn0804-4643-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/109220-
dc.description.abstractOBJECTIVE: Type-2 diabetes is a progressive disease. However, little is known about whether decreased fasting or postprandial pancreatic beta-cell responsiveness is more prominent with increased duration of diabetes. The aim of this study was to evaluate the relationship between insulin secretion both during fasting and 2 h postprandial, and the duration of diabetes in type-2 diabetic patients. DESIGN: Cross-sectional clinical investigation. METHODS: We conducted a meal tolerance test in 1466 type-2 diabetic patients and calculated fasting (M0) and postprandial (M1) beta-cell responsiveness. RESULTS: The fasting C-peptide, postprandial C-peptide, M0, and M1 values were lower, but HbA1c values were higher, in patients with diabetes duration > 10 years than those in other groups. There was no difference in the HbA1c levels according to the tertiles of their fasting C-peptide level. However, in a group of patients with highest postprandial C-peptide tertile, the HbA1c values were significantly lower than those in other groups. After adjustment of age, sex, and body mass index (BMI), the duration of diabetes was found to be negatively correlated with fasting C-peptide (gamma = -0.102), postprandial C-peptide (gamma = -0.356), M0 (gamma = -0.263), and M1 (gamma = -0.315; P < 0.01 respectively). After adjustment of age, sex, and BMI, HbA1c was found to be negatively correlated with postprandial C-peptide (gamma = -0.264), M(0) (gamma = -0.379), and M1 (gamma = -0.522), however, positively correlated with fasting C-peptide (gamma = 0.105; P < 0.01 respectively). In stepwise multiple regression analysis, M0, M1, and homeostasis model assessment for insulin resistance (HOMA-IR) emerged as predictors of HbAlc after adjustment for age, sex, and BMI (R2 = 0.272, 0.080, and 0.056 respectively). CONCLUSIONS: With increasing duration of diabetes, the decrease of postprandial insulin secretion is becoming more prominent, and postprandial beta-cell responsiveness may be a more important determinant for glycemic control than fasting beta-cell responsiveness.-
dc.description.statementOfResponsibilityopen-
dc.format.extent615~622-
dc.relation.isPartOfEUROPEAN JOURNAL OF ENDOCRINOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAdult-
dc.subject.MESHAged-
dc.subject.MESHBiomarkers/blood-
dc.subject.MESHC-Peptide/blood-
dc.subject.MESHCross-Sectional Studies-
dc.subject.MESHDiabetes Mellitus, Type 2/metabolism*-
dc.subject.MESHDisease Progression-
dc.subject.MESHFasting/blood-
dc.subject.MESHFemale-
dc.subject.MESHGlycated Hemoglobin A/analysis-
dc.subject.MESHHumans-
dc.subject.MESHInsulin/metabolism*-
dc.subject.MESHInsulin Secretion-
dc.subject.MESHInsulin-Secreting Cells/metabolism-
dc.subject.MESHMale-
dc.subject.MESHMiddle Aged-
dc.subject.MESHPostprandial Period-
dc.subject.MESHRegression Analysis-
dc.subject.MESHStatistical Distributions-
dc.titleDecrement of postprandial insulin secretion determines the progressive nature of type-2 diabetes-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorWan Sub Shim-
dc.contributor.googleauthorSoo Kyung Kim-
dc.contributor.googleauthorHae Jin Kim-
dc.contributor.googleauthorEun Seok Kang-
dc.contributor.googleauthorChul Woo Ahn-
dc.contributor.googleauthorSung Kil Lim-
dc.contributor.googleauthorHyun Chul Lee-
dc.contributor.googleauthorBong Soo Cha-
dc.identifier.doi10.1530/eje.1.02249-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA02270-
dc.contributor.localIdA03301-
dc.contributor.localIdA03375-
dc.contributor.localIdA03996-
dc.contributor.localIdA00068-
dc.relation.journalcodeJ00819-
dc.identifier.eissn1479-683X-
dc.identifier.pmid16990662-
dc.contributor.alternativeNameAhn, Chul Woo-
dc.contributor.alternativeNameLee, Hyun Chul-
dc.contributor.alternativeNameLim, Sung Kil-
dc.contributor.alternativeNameCha, Bong Soo-
dc.contributor.alternativeNameKang, Eun Seok-
dc.contributor.affiliatedAuthorAhn, Chul Woo-
dc.contributor.affiliatedAuthorLee, Hyun Chul-
dc.contributor.affiliatedAuthorLim, Sung Kil-
dc.contributor.affiliatedAuthorCha, Bong Soo-
dc.contributor.affiliatedAuthorKang, Eun Seok-
dc.rights.accessRightsfree-
dc.citation.volume155-
dc.citation.number4-
dc.citation.startPage615-
dc.citation.endPage622-
dc.identifier.bibliographicCitationEUROPEAN JOURNAL OF ENDOCRINOLOGY, Vol.155(4) : 615-622, 2006-
dc.identifier.rimsid55768-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.